Patriot Investment Management Inc. Nu Cana PLC Transaction History

Patriot Investment Management Inc.

  • $1.36 Billion
  • Q3 2024

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2020

Oct 23, 2020
SELL
$4.57 - $6.48 $228 - $324
-50 Closed
0 $0
Q2 2020

Aug 11, 2020
BUY
$4.87 - $7.37 $243 - $368
50 New
50 $0

Others Institutions Holding NCNA

# of Institutions
1
Shares Held
3.33M
Call Options Held
0
Put Options Held
0
View Full List

About NuCana plc

NCNA Quotes by TradingView
  • Ticker NCNA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 52,196,000
  • Market Cap $63.2M
  • Description
  • NuCana plc, a clinical-stage biopharmaceutical company, engages in the development of products for the treatment of cancer. The company develops its products based on its proprietary ProTide technology. Its lead product candidate includes Acelarin, which is in Phase I clinical trial for patients with advanced solid tumors; Phase Ib for patients ...
More about NCNA
Track This Portfolio

Track Patriot Investment Management Inc. Portfolio

Follow Patriot Investment Management Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Patriot Investment Management Inc., based on Form 13F filings with the SEC.

News

Stay updated on Patriot Investment Management Inc. with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email